首页> 外文OA文献 >Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies

【2h】

Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies

机译：Elagolix，口服促性腺激素 - 释放激素拮抗剂，用于治疗子宫内膜异位症相关的疼痛：安全性和有效性来自两个双盲，随机，安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H.S. Taylor; L.C. Giudice; B.A. Lessey; M. Abrao; J. Kotarski; L.A. Williams; J.P. Rowan; K. Chwalisz; W.R. Duan; B. Schwefel; J.W. Thomas; R.I. Jain;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain [J] . Hugh S Taylor, Erica C Dun, Kristof Chwalisz Pain management . 2019,第5期

机译：口服促性腺激素释放激素 - 拮抗剂Elagolix用于治疗子宫内膜异位症相关疼痛的临床评价
2. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase [J] . Manning Donald C., Gimbel Joseph, Wertz Robert, Pain medicine : . 2017,第3期

机译：Lenalal族疼痛中Lenalidomide在Lenalal突出疼痛中的一期随机，双盲，安慰剂控制的安全性和疗效研究A II期随机，双盲，安慰剂对照安全性和Lenalidomide的疗效研究在腰部疼痛的长期开放标签扩展阶段
3. Elagolix treatment for endometriosis-associated pain: Results from a phase 2, randomized, double-blind, placebo-controlled study [J] . DiamondM.P., CarrB., DmowskiW.P., Reproductive sciences . 2014,第3期

机译：Elagolix治疗子宫内膜异位症相关疼痛：第2期，随机，双盲，安慰剂对照研究的结果
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A randomized, double-blind, placebo-controlled phase II trial to examine the effect of polyphenon E on endogenous hormone levels [D] . Ling, Chen 2009

机译：一项随机，双盲，安慰剂对照的II期临床试验，用于研究多肽E对内源激素水平的影响
6. Elagolix an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study [O] . Bruce Carr, Linda Giudice, W. Paul Dmowski, -1

机译：Elagolix用于子宫内膜异位症相关疼痛的口服GnRH拮抗剂：一项随机对照研究。
7. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study [O] . Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, 2021

机译：Relugolix是一种口服促性腺激素释放激素受体拮抗剂，以剂量反应方式减少子宫内膜异位症相关的疼痛：随机，双盲，安慰剂对照研究

Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies

著录项

引文网络

相似文献

相关主题

期刊订阅